Twelve dogs were divided into two groups of six each, and were infused
with bis-3,5-dibromosalicyl fumarate stroma-free hemoglobin (DBBF-Hb)
or albumin. Their responses to an intravenous bolus of Escherichia co
li were followed for 4 hr. Bacterial clearance from the blood stream w
as studied using standard colony counting methodology as well as blood
counts, blood chemistries, and clotting factor analysis. There was a
significant difference in mean arterial pressure (MAP) over time betwe
en DBBF-Hb-treated dogs and those treated with albumin (P < 0.02). Whi
le the DBBF-treated dogs had a higher MAP during the 1 0 min of bacter
emia, after 1 hr, there were no longer any appreciable differences bet
ween septic dogs treated with DBBF-Hb vs. albumin. Consumption of clot
ting and natural anticoagulant factors was observed to be similar in b
oth groups, as were endotoxin levels. Blood urea nitrogen (BUN) increa
sed slightly in both groups, while white blood cell counts and clottin
g factor levels fell in both groups in a similar fashion. There was a
more pronounced fall (P < 0.04) in platelet counts in the animals trea
ted with DBBF-Hb. In the dogs treated with DBBF-Hb, there was also a l
ate rise in pCO2 (P < 0.01), a more pronounced fall in pO2, and greate
r acidosis, which suggested that ventilation perfusion abnormalities m
ay have been exacerbated by DBBF-Hb treatment. Since the exacerbation
of respiratory abnormalities was not related to diminished bacterial o
r endotoxin clearance, the possibility is raised that DBBF-Hb interfer
es with compensatory respiratory changes during sepsis. (C) 1993 Wiley
-Liss, Inc.